ARCHIVES

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014